Yin, C., Ethier, J., Carey, M. S., Tu, D., & Zheng, X. Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial. MDPI AG.
Chicago Style (17th ed.) CitationYin, Chang, Josee-Lyne Ethier, Mark S. Carey, Dongsheng Tu, and Xueying Zheng. Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial. MDPI AG.
MLA (9th ed.) CitationYin, Chang, et al. Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial. MDPI AG.